Skip to main content

Matisse Capital

SEC CIK
0001668256
Latest filing
Aug 12, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Matisse Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
1,550
Value
$599.4K
% of portfolio
0.2%
Quarters held
20
Since Q1 2021
Holdings of ELV by Matisse Capital, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,550$599.4K0.2%+1,550NewHolders
Q1 20260$00.0%−2,250−100.0%Sold outHolders
Q4 20252,250$788.7K0.4%00.0%UnchangedHolders
Q3 20252,250$727.0K0.3%−100−4.3%ReducedHolders
Q2 20252,350$914.1K0.4%00.0%UnchangedHolders
Q1 20252,350$1.02M0.5%00.0%UnchangedHolders
Q4 20242,350$866.9K0.4%−200−7.8%ReducedHolders
Q3 20242,550$1.33M0.6%00.0%UnchangedHolders
Q2 20242,550$1.38M0.7%−137−5.1%ReducedHolders
Q1 20242,687$1.39M0.7%−200−6.9%ReducedHolders
Q4 20232,887$1.36M0.7%+1,400+94.1%AddedHolders
Q3 20231,487$647.5K0.5%−2,000−57.4%ReducedHolders
Q2 20233,487$1.55M1.0%00.0%UnchangedHolders
Q1 20233,487$1.60M1.0%00.0%UnchangedHolders
Q4 20223,487$1.79M1.6%+3,487NewHolders
Q3 20220$00.0%−3,622−100.0%Sold outHolders
Q2 20223,622$1.75M1.7%00.0%UnchangedHolders
Q1 20223,622$1.78M1.6%+350+10.7%AddedHolders
Q4 20213,272$1.52M1.0%−1,000−23.4%ReducedHolders
Q3 20214,272$1.59M0.6%00.0%UnchangedHolders
Q2 20214,272$1.63M0.5%+2,000+88.0%AddedHolders
Q1 20212,272$815.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.